Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care

Gerald Pierone Jr1 Department of Adult Primary Care, Whole Family Health Center, Vero Beach, FL, USA

Laurence Brunet2 Department of Epidemiology, Epividian, Raleigh, NC, USACorrespondence[email protected]

Jennifer S Fusco2 Department of Epidemiology, Epividian, Raleigh, NC, USA

Cassidy E Henegar3 Epidemiology and Real World Evidence, ViiV Healthcare, Research Triangle Park, NC, USA

Supriya Sarkar3 Epidemiology and Real World Evidence, ViiV Healthcare, Research Triangle Park, NC, USA

Jean Van Wyk4 Global Medical, ViiV Healthcare, Brentford, UK

Vani Vannappagari3 Epidemiology and Real World Evidence, ViiV Healthcare, Research Triangle Park, NC, USA

Michael B Wohlfeiler5 Department of Medicine, AIDS Healthcare Foundation, Miami, FL, USA

Gregory P Fusco2 Department of Epidemiology, Epividian, Raleigh, NC, USA

Your download is now in progress and you may close this window